Medpace Holdings, Inc. (MEDP)
612.92
-15.68
(-2.49%)
USD |
NASDAQ |
Oct 16, 15:01
Medpace Holdings SG&A Expense (TTM) : 189.02M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 189.02M |
| March 31, 2026 | 187.58M |
| December 31, 2025 | 197.56M |
| September 30, 2025 | 198.08M |
| June 30, 2025 | 199.21M |
| March 31, 2025 | 194.00M |
| December 31, 2024 | 180.18M |
| September 30, 2024 | 177.26M |
| June 30, 2024 | 169.46M |
| March 31, 2024 | 167.41M |
| December 31, 2023 | 161.35M |
| September 30, 2023 | 152.24M |
| June 30, 2023 | 146.25M |
| March 31, 2023 | 140.06M |
| December 31, 2022 | 131.40M |
| September 30, 2022 | 125.66M |
| June 30, 2022 | 118.29M |
| March 31, 2022 | 112.05M |
| December 31, 2021 | 108.42M |
| September 30, 2021 | 103.14M |
| June 30, 2021 | 97.89M |
| March 31, 2021 | 92.77M |
| December 31, 2020 | 92.16M |
| Date | Value |
|---|---|
| September 30, 2020 | 91.04M |
| June 30, 2020 | 97.36M |
| March 31, 2020 | 99.06M |
| December 31, 2019 | 95.24M |
| September 30, 2019 | 94.55M |
| June 30, 2019 | 84.04M |
| March 31, 2019 | 80.99M |
| December 31, 2018 | 75.68M |
| September 30, 2018 | 71.95M |
| June 30, 2018 | 69.95M |
| March 31, 2018 | 64.20M |
| December 31, 2017 | 63.36M |
| September 30, 2017 | 63.30M |
| June 30, 2017 | 63.08M |
| March 31, 2017 | 63.15M |
| December 31, 2016 | 61.51M |
| September 30, 2016 | 44.72M |
| June 30, 2016 | 43.63M |
| March 31, 2016 | 28.80M |
| December 31, 2015 | 15.30M |
| September 30, 2015 | 15.30M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| IQVIA Holdings, Inc. | 2.058B |
| Avantor, Inc. | 1.599B |
| Champions Oncology, Inc. | 21.81M |
| Personalis, Inc. | 67.03M |
| Adaptive Biotechnologies Corp. | 180.38M |